Caisse DE Depot ET Placement DU Quebec Trims Position in Stryker Co. (SYK)
Caisse DE Depot ET Placement DU Quebec decreased its holdings in Stryker Co. (NYSE:SYK) by 39.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,229 shares of the medical technology company’s stock after selling 10,600 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Stryker were worth $2,513,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in SYK. Cornerstone Capital Management Holdings LLC. raised its position in Stryker by 3.1% during the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 55,255 shares of the medical technology company’s stock worth $7,847,000 after buying an additional 1,683 shares during the last quarter. Steward Partners Investment Advisory LLC purchased a new position in Stryker during the 3rd quarter worth $538,000. State of Alaska Department of Revenue raised its position in Stryker by 216.4% during the 4th quarter. State of Alaska Department of Revenue now owns 48,095 shares of the medical technology company’s stock worth $7,445,000 after buying an additional 32,892 shares during the last quarter. Signature Estate & Investment Advisors LLC raised its position in Stryker by 5.7% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 14,958 shares of the medical technology company’s stock worth $2,316,000 after buying an additional 804 shares during the last quarter. Finally, Nuance Investments LLC raised its position in Stryker by 10.8% during the 3rd quarter. Nuance Investments LLC now owns 24,624 shares of the medical technology company’s stock worth $3,497,000 after buying an additional 2,406 shares during the last quarter. Hedge funds and other institutional investors own 75.71% of the company’s stock.
SYK has been the subject of a number of analyst reports. ValuEngine upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Robert W. Baird upgraded shares of Stryker from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $161.00 to $173.00 in a research report on Thursday, November 16th. SunTrust Banks restated a “buy” rating and set a $161.00 price objective on shares of Stryker in a research report on Friday, November 17th. Needham & Company LLC restated a “hold” rating on shares of Stryker in a research report on Thursday, December 7th. Finally, BMO Capital Markets upgraded shares of Stryker to a “market perform” rating and set a $163.00 price objective for the company in a research report on Tuesday, December 12th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Stryker currently has an average rating of “Buy” and an average target price of $163.85.
Stryker Co. (NYSE SYK) opened at $167.11 on Wednesday. The firm has a market cap of $62,940.00, a price-to-earnings ratio of 34.10, a PEG ratio of 2.39 and a beta of 0.70. Stryker Co. has a 12 month low of $129.82 and a 12 month high of $170.00. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29.
Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, beating the Zacks’ consensus estimate of $1.95 by $0.01. The firm had revenue of $3.47 billion for the quarter, compared to analysts’ expectations of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.56%. The firm’s revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the company earned $1.78 EPS. research analysts predict that Stryker Co. will post 7.12 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be paid a $0.47 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $1.88 dividend on an annualized basis and a yield of 1.13%. Stryker’s payout ratio is 38.37%.
TRADEMARK VIOLATION NOTICE: This news story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/03/14/caisse-de-depot-et-placement-du-quebec-trims-position-in-stryker-co-syk.html.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.